Relax Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 4.75 Cr
as on 16-11-2024
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.98 Cr
as on 16-11-2024
- Satisfied Charges ₹ 13.75 Cr
as on 16-11-2024
- Revenue 26.29%
(FY 2023)
- Profit 18.71%
(FY 2023)
- Ebitda -20.92%
(FY 2023)
- Net Worth 23.96%
(FY 2023)
- Total Assets 12.31%
(FY 2023)
About Relax Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.75 Cr.
The company currently has active open charges totaling ₹19.98 Cr. The company has closed loans amounting to ₹13.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jigneshbhai Patel, Nileshkumar Patel, Bhavin Mangrolia, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230GJ2012PTC070558
- Company No.
070558
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Relax Biotech Private Limited offer?
Relax Biotech Private Limited offers a wide range of products and services, including Allopathic Cough Syrup, Zedex Syrup, Antibacterial Drugs, Ofloxacin Ornidazole Tablets, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Antibiotic Tablets & Capsules, Cefpodoxime Proxetil Capsules, Anti Infective Drugs & Medicines, Common Disease Medicines.
Who are the key members and board of directors at Relax Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jigneshbhai Patel  | Director | 01-Jun-2012 | Current |
Nileshkumar Patel  | Director | 01-Jun-2012 | Current |
| Bhavin Mangrolia | Director | 01-Apr-2018 | Current |
| Devang Shah | Director | 01-Apr-2018 | Current |
Financial of Relax Biotech.
Relax Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.29% increase. The company also saw a substantial improvement in profitability, with a 18.71% increase in profit. The company's net worth Soared by an impressive increase of 23.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Relax Biotech?
In 2023, Relax Biotech had a promoter holding of 100.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Mar 2023 | ₹9.99 Cr | Open |
Others Creation Date: 07 Mar 2023 | ₹9.99 Cr | Open |
Yes Bank Limited Creation Date: 18 Sep 2018 | ₹5.00 Cr | Satisfied |
How Many Employees Work at Relax Biotech?
Relax Biotech has a workforce of 133 employees as of Oct 14, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Relax Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relax Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
